Artia Global Partners Lp Top Holdings and 13F Report (2026)

About Artia Global Partners Lp

Investment Activity

Artia Global Partners Lp has $499.42 million in total holdings as of March 31, 2026.
Artia Global Partners Lp owns shares of 49 different stocks, but just 14 companies or ETFs make up 80% of its holdings.
Approximately 13.30% of the portfolio was purchased this quarter.
About 45.09% of the portfolio was sold this quarter.
This quarter, Artia Global Partners Lp has purchased 50 new stocks and bought additional shares in 6 stocks.
Artia Global Partners Lp sold shares of 11 stocks and completely divested from 12 stocks this quarter.

Largest Holdings

Insmed: $148,543,530
ABIVAX SA: $66,893,178
Eli Lilly and Company: $35,153,609
Trevi Therapeutics: $24,022,272
argenex: $21,716,905

Largest New Holdings this Quarter

G0593M107 - AstraZeneca: $18,810,055 Holding
60770K107 - Moderna: $10,160,000 Holding
022307102 - ALUMIS INC: $7,160,763 Holding
58933Y105 - Merck & Co., Inc.: $5,617,543 Holding
880881107 - Terns Pharmaceuticals: $5,525,056 Holding

Largest Purchases this Quarter

AstraZeneca: 95,376 shares (about $18.81M)
Moderna: 200,000 shares (about $10.16M)
ALUMIS INC: 325,046 shares (about $7.16M)
Merck & Co., Inc.: 46,700 shares (about $5.62M)
Terns Pharmaceuticals: 104,800 shares (about $5.53M)

Largest Sales this Quarter

Insmed: 193,800 shares (about $31.69M)
argenex: 34,960 shares (about $25.53M)
Viking Therapeutics: 538,634 shares (about $17.53M)
Soleno Therapeutics: 515,208 shares (about $17.25M)
Eli Lilly and Company: 12,280 shares (about $11.29M)

Sector Allocation Over Time

Selling

Neutral

Buying

Latest 13F Holdings and Changes Since Previous Quarterly Filing

Issuer Name	Holdings Value	Approximate Purchase/Sale	Change in Shares	Shares Held	% of Portfolio	Sector
INSM Insmed	$148,543,530	$31,690,176 â–¼	-17.6%	908,412	29.7%	Medical
ABIVAX SA	$66,893,178	$1,102,365 â–¼	-1.6%	600,747	13.4%	SPONSORED ADS
LLY Eli Lilly and Company	$35,153,609	$11,294,775 â–¼	-24.3%	38,220	7.0%	Medical
TRVI Trevi Therapeutics	$24,022,272		0.0%	2,013,602	4.8%	Medical
ARGX argenex	$21,716,905	$25,529,540 â–¼	-54.0%	29,739	4.3%	Medical
AZNCF AstraZeneca	$18,810,055	$18,810,055 â–²	New Holding	95,376	3.8%	Medical
NAMS NewAmsterdam Pharma	$16,130,991		0.0%	503,936	3.2%	Medical
DIANTHUS THERAPEUTICS INC	$13,678,121	$3,533,032 â–¼	-20.5%	162,990	2.7%	COM
RVMD Revolution Medicines	$12,155,278	$2,022,800 â–²	20.0%	124,990	2.4%	Medical
IONS Ionis Pharmaceuticals	$10,841,194		0.0%	144,376	2.2%	Medical
MRNA Moderna	$10,160,000	$10,160,000 â–²	New Holding	200,000	2.0%	Medical
EYPT Eyepoint Pharmaceuticals	$9,887,893		0.0%	767,098	2.0%	Medical
DGX Quest Diagnostics	$7,999,316		0.0%	40,817	1.6%	Medical
ALUMIS INC	$7,160,763	$7,160,763 â–²	New Holding	325,046	1.4%	COM
VKTX Viking Therapeutics	$5,880,987	$17,527,151 â–¼	-74.9%	180,731	1.2%	Medical
MRK Merck & Co., Inc.	$5,617,543	$5,617,543 â–²	New Holding	46,700	1.1%	Medical
TERN Terns Pharmaceuticals	$5,525,056	$5,525,056 â–²	New Holding	104,800	1.1%	Medical
JNJ Johnson & Johnson	$5,524,344	$5,524,344 â–²	New Holding	22,600	1.1%	Medical
SIONNA THERAPEUTICS INC	$4,800,417		0.0%	119,741	1.0%	COM
SRRK Scholar Rock	$4,733,371		0.0%	96,285	0.9%	Medical
RAPPORT THERAPEUTICS INC	$4,333,915		0.0%	138,508	0.9%	COM
ASND Ascendis Pharma A/S	$4,057,670		0.0%	17,740	0.8%	Medical
BLTE Belite Bio	$3,984,246	$1,116,080 â–²	38.9%	24,989	0.8%	Medical
XENE Xenon Pharmaceuticals	$3,779,750	$1,453,750 â–²	62.5%	65,000	0.8%	Medical
MLYS Mineralys Therapeutics	$3,733,002		0.0%	137,800	0.7%	Medical
ROIV Roivant Sciences	$3,595,460		0.0%	129,800	0.7%	Medical
PALISADE BIO INC	$3,486,642		0.0%	1,992,367	0.7%	COM
BIIB Biogen	$3,380,055	$3,380,055 â–²	New Holding	18,437	0.7%	Medical
PROKIDNEY CORP	$3,234,421	$56,335 â–¼	-1.7%	1,806,939	0.6%	SHS CL A
ABBV AbbVie	$3,153,605		0.0%	14,500	0.6%	Medical
UTHR United Therapeutics	$2,964,900		0.0%	5,000	0.6%	Medical
BRIGHT MINDS BIOSCIENCES INC	$2,802,559	$364,850 â–²	15.0%	38,407	0.6%	COM NEW
PTGX Protagonist Therapeutics	$2,416,927	$2,108 â–¼	-0.1%	22,931	0.5%	Medical
SLNO Soleno Therapeutics	$2,293,045	$17,249,162 â–¼	-88.3%	68,490	0.5%	Medical
BRIGHTSPRING HEALTH SVCS INC	$2,292,418	$519,842 â–²	29.3%	53,800	0.5%	COM
TVTX Travere Therapeutics	$2,100,497		0.0%	70,700	0.4%	Medical
EWTX Edgewise Therapeutics	$2,063,250	$2,063,250 â–²	New Holding	65,500	0.4%	Medical
CELC Celcuity	$1,777,845	$305,439 â–²	20.7%	15,576	0.4%	Medical
BBIO BridgeBio Pharma	$1,514,904		0.0%	20,400	0.3%	Medical
KINIKSA PHARMACEUTICALS INTL	$1,405,980		0.0%	29,200	0.3%	ORD SHS CL A
CYTK Cytokinetics	$1,074,333	$1,074,333 â–²	New Holding	16,300	0.2%	Medical
ELVN Enliven Therapeutics	$819,280	$819,280 â–²	New Holding	20,900	0.2%	Medical
PRAXIS PRECISION MEDICINES I	$805,475		0.0%	2,500	0.2%	COM NEW
TENAX THERAPEUTICS INC	$672,859		0.0%	42,080	0.1%	COM NEW
KOD Kodiak Sciences	$648,764		0.0%	17,019	0.1%	Medical
NUVL Nuvalent	$502,005	$327,840 â–¼	-39.5%	4,900	0.1%	Medical
APOGEE THERAPEUTICS INC	$495,425	$495,425 â–²	New Holding	5,886	0.1%	COM
AVALO THERAPEUTICS INC	$432,522	$188,118 â–¼	-30.3%	28,970	0.1%	COM NEW
PEPG PepGen	$363,423		0.0%	205,324	0.1%	Medical
UGL ProShares Ultra Gold	$0	$30,098,447 â–¼	-100.0%	0	0.0%	ETF
QURE uniQure	$0	$24,493,288 â–¼	-100.0%	0	0.0%	Medical
ASTRAZENECA PLC	$0	$17,535,831 â–¼	-100.0%	0	0.0%	SPONSORED ADR
CIDARA THERAPEUTICS INC	$0	$15,644,313 â–¼	-100.0%	0	0.0%	COM NEW
ALNY Alnylam Pharmaceuticals	$0	$6,919,110 â–¼	-100.0%	0	0.0%	Medical
VTYX Ventyx Biosciences	$0	$6,284,717 â–¼	-100.0%	0	0.0%	Medical
PALVELLA THERAPEUTICS INC NE	$0	$6,196,464 â–¼	-100.0%	0	0.0%	COM
RNA Avidity Biosciences	$0	$4,335,013 â–¼	-100.0%	0	0.0%	Medical
OCUL Ocular Therapeutix	$0	$2,746,809 â–¼	-100.0%	0	0.0%	Medical
UPSTREAM BIO INC	$0	$1,863,929 â–¼	-100.0%	0	0.0%	COM
ALTO NEUROSCIENCE INC	$0	$519,618 â–¼	-100.0%	0	0.0%	COM SHS
LYRA THERAPEUTICS INC	$0	$26,968 â–¼	-100.0%	0	0.0%	COM NEW

Showing largest 100 holdings. View all holdings.

More Institutional Buying and Selling Information

SEC Filings and Trading Data

Get 30 Days of MarketBeat All Access for Free

Start Your 30-Day Trial

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Artia Global Partners Lp Top Holdings and 13F Report (2026)

About Artia Global Partners Lp

Investment Activity

Largest Holdings

Largest New Holdings this Quarter

Largest Purchases this Quarter

Largest Sales this Quarter

Sector Allocation Over Time

Latest 13F Holdings and Changes Since Previous Quarterly Filing

More Institutional Buying and Selling Information

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

Artia Global Partners Lp Top Holdings and 13F Report (2026)

About Artia Global Partners Lp

Investment Activity

Largest Holdings

Largest New Holdings this Quarter

Largest Purchases this Quarter

Largest Sales this Quarter

Sector Allocation Over Time

Map of 500 Largest Holdings ofArtia Global Partners Lp

Latest 13F Holdings and Changes Since Previous Quarterly Filing

More Institutional Buying and Selling Information

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools